Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2009 1
2012 1
2016 1
2021 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials.
Trinchieri A, Perletti G, Magri V, Stamatiou K, Trinchieri M, Montanari E. Trinchieri A, et al. Arch Ital Urol Androl. 2021 Dec 21;93(4):489-496. doi: 10.4081/aiua.2021.4.489. Arch Ital Urol Androl. 2021. PMID: 34933535 Free article.
Such effect can be explained by a modification of the testosterone to estradiol ratio. Gynecomastia (and galactorrhea) associated to the use of conventional and certain atypical antipsychotics can be related to high prolactin levels....
Such effect can be explained by a modification of the testosterone to estradiol ratio. Gynecomastia (and galactorrhea) associated to …
Galactorrhea/Galactocele After Breast Augmentation: A Systematic Review.
Sharma SC, Basu NN. Sharma SC, et al. Ann Plast Surg. 2021 Jan;86(1):115-120. doi: 10.1097/SAP.0000000000002290. Ann Plast Surg. 2021. PMID: 32079808
AIMS: To review cases of galactorrhea and galactocele postbreast augmentation, determine possible risk factors and consider management strategies of this rare complication. ...The average time to symptom onset was 61 days (range, 3-912 days) but only 3 cases presented more …
AIMS: To review cases of galactorrhea and galactocele postbreast augmentation, determine possible risk factors and consider managemen …
Treatment of hyperprolactinemia: a systematic review and meta-analysis.
Wang AT, Mullan RJ, Lane MA, Hazem A, Prasad C, Gathaiya NW, Fernández-Balsells MM, Bagatto A, Coto-Yglesias F, Carey J, Elraiyah TA, Erwin PJ, Gandhi GY, Montori VM, Murad MH. Wang AT, et al. Syst Rev. 2012 Jul 24;1:33. doi: 10.1186/2046-4053-1-33. Syst Rev. 2012. PMID: 22828169 Free PMC article. Review.
Cabergoline was more effective than bromocriptine in reducing persistent hyperprolactinemia, amenorrhea/oligomenorrhea, and galactorrhea. A large body of noncomparative literature showed dopamine agonists improved other patient-important outcomes. ...
Cabergoline was more effective than bromocriptine in reducing persistent hyperprolactinemia, amenorrhea/oligomenorrhea, and galactorrhea …
The impact of opioids on the endocrine system.
Katz N, Mazer NA. Katz N, et al. Clin J Pain. 2009 Feb;25(2):170-5. doi: 10.1097/AJP.0b013e3181850df6. Clin J Pain. 2009. PMID: 19333165 Review.
Symptoms of opioid-induced hypogonadism include loss of libido, infertility, fatigue, depression, anxiety, loss of muscle strength and mass, osteoporosis, and compression fractures in both men and women; impotence in men; and menstrual irregularities and galactorrhea in wo …
Symptoms of opioid-induced hypogonadism include loss of libido, infertility, fatigue, depression, anxiety, loss of muscle strength and mass, …
Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review.
Bo QJ, Wang ZM, Li XB, Ma X, Wang CY, de Leon J. Bo QJ, et al. Psychiatry Res. 2016 Mar 30;237:257-63. doi: 10.1016/j.psychres.2016.01.031. Epub 2016 Jan 16. Psychiatry Res. 2016. PMID: 26822064 Review.
In one observational study, 91% of patients no longer had signs or symptoms of galactorrhea. In the RCT, adverse drug reactions (ADRs) occurred at similar incidence rates among metformin and placebo patients, except that no significant increases in nausea, insomnia and agi …
In one observational study, 91% of patients no longer had signs or symptoms of galactorrhea. In the RCT, adverse drug reactions (ADRs …
Bromocriptine for unexplained subfertility in women.
Hughes E, Collins J, Vandekerckhove P. Hughes E, et al. Cochrane Database Syst Rev. 2000;(2):CD000044. doi: 10.1002/14651858.CD000044. Cochrane Database Syst Rev. 2000. PMID: 10796473 Updated. Review.
However trials for women with unexplained subfertility who also have expressible galactorrhea may be worthwhile....
However trials for women with unexplained subfertility who also have expressible galactorrhea may be worthwhile....
WITHDRAWN: Bromocriptine for unexplained subfertility in women.
Hughes E, Collins J, Vandekerckhove P. Hughes E, et al. Cochrane Database Syst Rev. 2007 Jul 18;1996(4):CD000044. doi: 10.1002/14651858.CD000044.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636576 Free PMC article. Review.
However trials for women with unexplained subfertility who also have expressible galactorrhea may be worthwhile....
However trials for women with unexplained subfertility who also have expressible galactorrhea may be worthwhile....